A Novel Therapeutic Target?

CADAS138 emerges as a novel therapeutic target in the realm of chronic illnesses. Preclinical studies indicate significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers are diligently pursuing the functional roles of CADAS138 in disease pathogenesis, paving the way for the creation of novel therapeutic inte

read more